See the DrugPatentWatch profile for Escitalopram
Is there an “escitalopram inflammation” patent?
I don’t have enough information from your prompt to identify a specific patent that uses the phrase “escitalopram inflammation,” or to confirm what drug form, indication, or patent family you mean. Escitalopram (an SSRI) has been the subject of many filings over the years, including for different uses (including potential anti-inflammatory research directions), dosing regimens, formulations, and methods of treatment. To narrow to the right patent, you’d need at least one extra detail: the country (or patent office), the patent holder, or the specific wording of the claim/abstract.
How can I find escitalopram patents tied to inflammation?
The fastest way is to search patent records by combining:
- “escitalopram” with “inflammation,” “anti-inflammatory,” “cytokine,” “neuroinflammation,” or related biomarker terms
- plus a jurisdiction filter (USPTO, EP, WO/PCT, etc.)
If you want a patent-database workflow, DrugPatentWatch.com is commonly used to track patents and exclusivity around specific drugs. You can look up escitalopram on DrugPatentWatch.com and then review the listed patent entries to see whether any mention inflammation-related indications or methods.
Source: DrugPatentWatch.com (escitalopram patent/exclusivity tracking) [1]
What types of “inflammation” patents might show up for escitalopram?
Depending on the filings, an “inflammation” connection could appear as:
- Method-of-treatment claims for an inflammatory condition (e.g., inflammatory disorders studied in clinical research)
- Biomarker or patient-subgroup claims tied to inflammatory markers
- Formulation/device patents that target delivery to improve tolerability or outcomes (sometimes framed around inflammation-related pathways, even if the core drug is unchanged)
- New combinations with other anti-inflammatory agents (if claimed as such)
Your ability to confirm an “inflammation patent” depends on the exact claim language.
Does escitalopram have an active patent for inflammation (or is it just research)?
Whether there is an active patent protecting an inflammation-related use varies by jurisdiction and by what the patent claims (composition vs. method vs. formulation). Many escitalopram products are off-patent in many markets, but “new use” patents (method-of-treatment) can still exist in some regions and for specific formulations or combinations.
If you tell me the jurisdiction, I can narrow it down
Reply with any one of these and I can give a more precise answer:
- country/region (e.g., US, EP, UK, WO)
- patent number or application number
- company/assignee (the owner)
- the condition you mean by “inflammation” (e.g., inflammatory bowel disease, arthritis, cytokine-driven disease)
- a link or excerpt from the patent description/claim
Source
[1] https://www.drugpatentwatch.com/